Figure 2
![Figure 2. Transplantation using donors with KIR B haplotypes improves overall survival. The univariate Kaplan-Meier curves for overall survival (OS) are shown for patients receiving transplants from donors with (KIR B/x; n = 317) or without (KIR A/A; n = 131) KIR B haplotypes. Survival is significantly better if the donor had a KIR B haplotype (31% [95% CI: 26-36] vs 20% [95% CI: 13-27]; P = .007).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/113/3/10.1182_blood-2008-07-171926/5/zh80020929410002.jpeg?Expires=1735535946&Signature=YcFIppB5DMUUX2yGmq~WTTuAMf3P02uBNgefKgsZDBzqK~ij2KbCt3u9YxVarpGGWlpswe3YvXIdWBrgZfxYm4onkPlyZu6FFSeNswhNPcISERtvLJSrTkcQ01kVgAfkTjHmQROug~6NwbRODrMLkZBdJTQ4PtBG6P2AkbxxKHJbUxOr8mmHt6diEvQXJALgmpeznytay-0Tg3DGdTIU6PB4hZ~v5bs2KF92EmKdJ7A2bnVSaW0uFxFuNsvKbuvBbsgAnEht6Ud537Z08HBgAHot1mIxQX4RYWsd4nZ2tBiNLHlME7rRa4EEyLl6HuOG610r7jTLcWLHYye74of~Mw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Transplantation using donors with KIR B haplotypes improves overall survival. The univariate Kaplan-Meier curves for overall survival (OS) are shown for patients receiving transplants from donors with (KIR B/x; n = 317) or without (KIR A/A; n = 131) KIR B haplotypes. Survival is significantly better if the donor had a KIR B haplotype (31% [95% CI: 26-36] vs 20% [95% CI: 13-27]; P = .007).
